Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.14 +0.11 (+2.85%)
As of: Sep 30, 2026 · 10:04 AM EDT

Recursion Pharmaceuticals (RXRX) Total Non-Current Liabilities (2020 - 2026)

Updated

Recursion Pharmaceuticals' Total Non-Current Liabilities was $294.96 million in Q2 2026, down 22.7% from $381.64 million a year earlier and down 5.7% from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Recursion Pharmaceuticals came in at $341.19 million, down 16.6% from FY2024.

  • Total Non-Current Liabilities shows a five-year compound annual growth rate of -7.4% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $409.08 million in FY2024 (+115.0%), $190.26 million in FY2023 (-11.7%), $215.48 million in FY2022 (+271.1%) and $58.07 million in FY2021 (-88.4%).
  • The Q2 2026 figure marks the lowest quarterly Total Non-Current Liabilities since Q3 2024.
  • Compared with a year earlier, Total Non-Current Liabilities has declined for three straight quarters, with growth averaging 40.0% over the last six quarters.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q2 2022 (growth of 342.8%); the worst was Q4 2021 (a decline of 88.4%).
  • Per Business Quant data, RXRX's Total Non-Current Liabilities in the three quarters before Q2 2026 was $312.73 million (Q1 2026), $341.19 million (Q4 2025) and $351.55 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Recursion Pharmaceuticals 1.98 Bn -627.04 Mn -3.82 Mn 294.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 294.96 Mn
Mar 31, 2026 312.73 Mn
Dec 31, 2025 341.19 Mn
Sep 30, 2025 351.55 Mn
Jun 30, 2025 381.64 Mn
Mar 31, 2025 366.50 Mn
Dec 31, 2024 409.08 Mn
Sep 30, 2024 198.94 Mn
Jun 30, 2024 188.41 Mn
Dec 31, 2023 190.26 Mn
Dec 31, 2022 215.48 Mn
Sep 30, 2022 223.50 Mn
Jun 30, 2022 234.94 Mn
Mar 31, 2022 240.75 Mn
Dec 31, 2021 58.07 Mn
Sep 30, 2021 56.11 Mn
Jun 30, 2021 53.06 Mn
Mar 31, 2021 502.22 Mn
Dec 31, 2020 502.17 Mn
API Access

Recursion Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RXRX&period=max&api_key=YOUR_API_KEY